Report
Long-acting insulin analogues in the treatment of diabetes mellitus type 1
Report documents
-
Executive summary of the final report
Long-acting insulin analogues in the treatment of diabetes mellitus type 1
-
Final report
Long-acting insulin analogues in the treatment of diabetes mellitus type 1
-
Documentation and evaluation of the hearing on the preliminary report
Long-acting insulin analogues in the treatment of diabetes mellitus type 1
-
Addendum to the documentation and evaluation of the hearing on the preliminary report
Long-acting insulin analogues in the treatment of diabetes mellitus type 1
-
Executive summary of the preliminary report
Long-acting insulin analogues in the treatment of diabetes mellitus type 1
-
Preliminary report
Long-acting insulin analogues in the treatment of diabetes mellitus type 1
-
Report plan version 2.0
Long-acting insulin analogues in the treatment of diabetes mellitus type 1
-
Documentation and appraisal of comments on the report plan version 1.0
Long-acting insulin analogues in the treatment of diabetes mellitus type 1
-
Amendment 1 to the report plan version 1.0
Long-acting insulin analogues in the treatment of diabetes mellitus type 1
-
Report plan version 1.0
Long-acting insulin analogues in the treatment of diabetes mellitus type 1
Press releases
Long-acting insulin analogues in type 1 diabetes: no proof of additional benefit compared to human insulin
Additional information
IQWiG health information
Project details
- Project no.
- A05-01
- Commission
- Commission awarded on 22.02.2005 by the Federal Joint Committee (GBA).
- Report type
- Report
- Status
- Commission completed
- Department/Division
- Drug Assessment
- Topic
- Digestion, metabolism and hormones